Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1990
11/28/1990EP0398880A1 Multiple stage affinity process for isolation of specific cells from a cell mixture
11/28/1990EP0114887B1 Polypeptide
11/28/1990CN1047208A Method for cultivating dog calculus by injecting mutagen "shengshiling"
11/27/1990US4973669 Immunoglobulins, immunoassay, purification
11/27/1990US4973551 Vector for the expression of fusion proteins and protein immunogens
11/27/1990CA1277100C Glycopeptides, process for their preparation and their use
11/27/1990CA1276899C Method for purifying a gene-expression product produced by recombinant dna technique
11/27/1990CA1276884C2 Protein antibody derived from serum of a bovid
11/27/1990CA1276883C2 Protein antibody composition derived from bovid milk and from avian egg
11/27/1990CA1276878C Radiolabeled antibody fragments
11/26/1990WO1990014595A1 Composition and method to detect sensitivity to alpha interferon therapy
11/26/1990CA2058420A1 Composition and method to detect sensitivity to alpha-interferon therapy
11/26/1990CA2057057A1 Interleukin-2 in treating birds
11/25/1990WO1990014361A1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
11/25/1990CA2033202A1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
11/22/1990EP0398753A2 Metalloproteinase inhibitor
11/22/1990EP0398748A2 NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
11/22/1990EP0398707A1 Treatment and diagnosis of human lymphotropic viruses
11/22/1990EP0398540A1 Malaria vaccine
11/22/1990EP0398443A1 Immunogenic compounds and their use in the preparation of genetically unrestricted synthetic vaccines and in the immunoenzymatic determination of antisporozoite antibodies of plasmodium malariae
11/22/1990EP0398327A1 Tumor necrosis factor binding protein II, its purification and antibodies thereto
11/22/1990EP0398322A1 Synthetic peptides capable of stimulating a T-cellular immunity
11/22/1990EP0398305A2 Anthracycline conjugates having a novel linker and methods for their production
11/22/1990EP0398288A2 Process for preparing optically active 2-arylalkanoic acids, in particular 2-arylpropionic acids
11/22/1990EP0398287A1 Pharmaceutical preparation
11/22/1990EP0397847A1 Diagnostic assay for breast cancer in human female patients
11/22/1990EP0397821A1 A novel family of high affinity, modified antibodies for cancer treatment
11/22/1990EP0397798A1 Therapeutic use of anti-t cell immunotoxin for autoimmune diseases
11/22/1990EP0397764A1 Method of reducing immunoglobulin e responses
11/22/1990CA2017236A1 Antibodies to human mammary cell growth inhibitor and methods of production and use
11/21/1990CN1047035A Novel antibody system for biological response modifiers
11/20/1990US4971801 Natural membranes vesicles and ribosomes
11/20/1990US4971795 Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype
11/20/1990US4971794 Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
11/20/1990US4971793 Subunit canine parvovirus vaccine
11/20/1990US4971792 Antitumor agents, anticarcinogenic agents, administering
11/20/1990CA1276574C Monoclonal antibodies to activated platelets
11/20/1990CA1276552C Conjugate vaccine against infections by gram-negative bacteria, method for its preparation and use
11/19/1990CA2017180A1 Synthetic peptides capable of stimulating a t-cellular immunity
11/18/1990WO1990014360A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/18/1990CA2458875A1 Tumor necrosis factor (tnf) binding protein ii, its purification and antibodies thereto
11/18/1990CA2056981A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/16/1990CA2016888A1 Pharmaceutical preparation
11/16/1990CA2016887A1 Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl propionic acids
11/15/1990WO1990013661A1 Autoantibodies which enhance the rate of a chemical reaction
11/15/1990WO1990013652A1 Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
11/15/1990WO1990013573A1 Polypeptides of feline t-cell lymphotropic lentivirus
11/15/1990WO1990013563A1 Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
11/15/1990WO1990013562A1 Chemically modified cd4 peptide fragments having anti-retroviral properties
11/15/1990WO1990013315A1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex
11/15/1990WO1990013314A2 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship
11/15/1990WO1990013313A1 Acellular vaccine
11/15/1990WO1990013312A1 Utilisation of adenyl cyclase or bacteria producing it used as vaccines against bordetella
11/15/1990WO1990013311A1 Vaccine for prophylaxis and treatment of microsporia caused by the pathogen microsporum canis
11/15/1990WO1990013300A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
11/14/1990EP0397633A2 Fibronectin binding protein as well as its preparation
11/14/1990EP0397419A2 Novel tumor-associated antigen, antibodies, compositions and uses therefor
11/14/1990EP0397409A1 The stabilization of organic compounds
11/14/1990EP0397213A1 Radiolabeled antibody fragments
11/14/1990EP0396964A1 Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
11/14/1990EP0396653A1 Recombinant fusion proteins for altering hormone secretion
11/14/1990EP0396560A1 Process for increasing the growth rate and/or utilization of fodder or foodstuffs and/or resistance in animals and humans.
11/14/1990EP0396552A1 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
11/14/1990CN1046937A 疟疾疫苗 Malaria Vaccine
11/14/1990CN1046851A Making method of triple live vaccine for chicken newcastle disease, infectious bronchitis and smallpox quailizing
11/14/1990CN1046850A Making method of chicken newcastle disease, chicken smallpox quailzing weak-poisonous two live vaccine
11/13/1990US4970303 Linking carbohydrate to thiol moieties
11/13/1990US4970296 Units composed of signal peptide, transmembrane, and cytoplasmic segments
11/13/1990US4970156 Immobilization of active protein by cross-linking to inactive protein
11/13/1990US4970071 Immunotherapeutic methods and compositions employing antigens characteristic of non human malignant neoplasms
11/13/1990CA1276109C Immunogenic conjugates
11/13/1990CA1276108C Process for modifying ribosome-inactivating glycoproteins by oxidation of their osidic units and formation of a schiff's base
11/13/1990CA1276106C Process and reagent for the specific determination of pancreatic alpha-amylase
11/13/1990CA1276104C Method for determining human prolyl hydroxylase by radioimmunoassay
11/11/1990WO1990013641A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
11/11/1990CA2055435A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
11/10/1990CA2016385A1 Tumor-associated antigen, antibodies, compositions and uses therefor
11/08/1990CA2016183A1 Polypeptides of feline t-cell lymphotropic lentivirus
11/08/1990CA2016165A1 Stabilization of organic compounds
11/07/1990EP0396505A2 Monoclonal antibodies specific for an immunoglobulin isotype
11/07/1990EP0396387A2 A novel antibody delivery system for biological response modifiers
11/07/1990EP0396193A1 Canine corona virus vaccine
11/07/1990EP0396188A1 Antibodies against fibrin; immunogenic peptides suitable for preparing the antibodies, method for determining fibrin and pharmaceutical preparation based on the antibodies
11/07/1990EP0395706A1 Production of gonorrheal pi proteins and vaccines
11/07/1990EP0395669A1 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes
11/07/1990CN1046759A Retinoblastoma gene product antibodies and uses therefor
11/06/1990US4968715 Use of purified hematoporphyrin trimers in photodynamic therapy
11/06/1990US4968627 Vaccines, diagnosis
11/06/1990US4968607 Interleukin-1 receptors
11/06/1990CA1275952C Monoclonal antibodies against metal chelates
11/06/1990CA1275951C Lysing or blocking unwanted cells
11/04/1990WO1990013630A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these
11/04/1990WO1990013564A1 Synthetic peptides for an hiv-1 vaccine
11/04/1990CA2054720A1 Highly cytopathogenic hiv-ndk retrovirus, adn fragments thereof, process for the preparation of a protein and/or enzyme thereof and uses thereof
11/04/1990CA2015888A1 Monoclonal antibodies specific for an immunoglobulin isotype
11/04/1990CA2015862A1 Cell surface antigen that binds with l6 monoclonal antibody
11/03/1990WO1990014068A2 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
11/03/1990CA2032138A1 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
11/03/1990CA2015722A1 Malaria vaccine
11/01/1990WO1990013032A1 Extraction procedure
1 ... 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 ... 1823